Hikma Pharmaceuticals LSE:HIK FTSE 100 Brings Pipeline And Ownership News Back Into Focus For UK Shares

1 source ·1 article ·Aug 27, 11:41 UTC Astrazeneca

Highlights Hikma Pharmaceuticals is in focus because generic and injectable medicines exposure amid resilient healthcare demand. Spire Healthcare Group (LSE:SPI) and AstraZeneca (LSE:AZN) show that the category is responding selectively aro…

Covered by 1 outlet

Kalkinemedia 1

All coverage · 1 article

Kalkine Media UK ·Aug 27, 11:41 UTC

Hikma Pharmaceuticals LSE:HIK FTSE 100 Brings Pipeline And Ownership News Back Into Focus For UK Shares

Hikma Pharmaceuticals LSE:HIK FTSE 100 Brings Pipeline And Ownership News Back Into Focus For UK Shares →

Hikma Pharmaceuticals LSE:HIK FTSE 100 Brings Pipeline And Ownership News Back Into Focus For UK Shares